Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.
Looking for a particular Lonza employee's phone or email?
The Lonza annual revenue was $7.9 billion in 2026.
Daniel Palmacci is the President and Head Specialized Modalities, Member of Lonza Executive Committee of Lonza.
13,205 people are employed at Lonza.
Lonza is based in Basel, Basel-City.
The NAICS codes for Lonza are [32, 32541, 54, 3254, 541, 325].
The SIC codes for Lonza are [2833, 2834, 283, 28].